DURHAM / LONDON (IT BOLTWISE) – Researchers at Duke Health have made significant progress in developing a vaccine against breast cancer. A small group of women with advanced breast cancer who participated in a clinical trial are showing impressive results. All participants are still alive today and have strong, long-lasting immune cells that recognize their cancer.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
The recent results of a Duke Health clinical trial have caused a stir in the medical community. The study, which began more than two decades ago, examined the effects of a vaccine in women with advanced breast cancer. Remarkably, all of the study participants are still alive today and demonstrate a robust immune response that recognizes and fights their cancer cells.
One of the participants, Lori Lober, was originally given a grim prognosis, with a survival rate of less than 2 to 3 percent over five years. But thanks to taking part in the study, she has been cancer-free for 24 years. Lober describes herself as one of the most blessed people in the world and lives her life to the fullest.
Dr. Duke Health’s Zachary Hartman emphasizes the potential of immunotherapy. He explains that this method not only temporarily suppresses cancer cells, but trains the body’s immune system to actively fight these cells. This approach could fundamentally change the way cancer is treated.
Researchers are optimistic that this approach could significantly advance cancer treatment in the future. The study shows that immunotherapies are not just a theoretical possibility, but can already deliver tangible results today. This could pave the way for further research and development in this area.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Breast cancer vaccination breakthrough: New hope for patients”.